Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia

被引：0
|
作者：
Wang, Lijun [1 ]
Chen, Yu [2 ]
Wang, Qingyuan [1 ]
Xiang, Meng [1 ]
Zeng, Zhao [1 ]
Zhang, Zhibo [1 ]
Zhang, Fenghong [1 ]
Chen, Suning [1 ,3 ,4 ]
Xue, Mengxing [1 ,4 ]
机构：
[1] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Wannan Med Coll, Dept Hematol, Affiliated Hosp 2, Wuhu, Peoples R China
[3] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suning Chen & Mengxing Xue, Shizi St 188, Suzhou 215006, Peoples R China
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2024年 / 46卷 / 03期
基金：
中国国家自然科学基金;
关键词：
PAX5; TRANSFORMATION; GENE;
D O I：
10.1111/ijlh.14245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 574
页数：4
相关论文
共 50 条
  • [1] Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion presenting with leonine facies
    Wankel, Bret
    Afzal, Muhammad
    Loo, Eric Y.
    Leblanc, Robert E.
    Carter, Joi B.
    Lansigan, Erick
    Yerrabothala, Swaroopa
    LEUKEMIA RESEARCH REPORTS, 2024, 21
  • [2] HCVAD Plus Imatinib or Dasatinib in Lymphoid Blastic Phase Chronic Myeloid Leukemia
    Strati, Paolo
    Kantarjian, Hagop
    Thomas, Deborah
    O'Brien, Susan
    Konoplev, Sergej
    Jorgensen, Jeffrey L.
    Luthra, Raja
    Abruzzo, Lynne
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan
    Ravandi, Farhad
    Cortes, Jorge
    CANCER, 2014, 120 (03) : 373 - 380
  • [3] Hypercvad Plus Imatinib or Dasatinib for Patients with Lymphoid Blastic Phase of Chronic Myeloid Leukemia
    Strati, Paolo
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    O'Brien, Susan M.
    Jabbour, Elias J.
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan
    Ravandi, Farhad
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [4] De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion
    Hameed, Maha
    Alnoamani, Mohammed
    Marei, Mohammed
    Tailor, Imran
    Alshehri, Hassan
    Tashkandi, Soha A. A.
    Alswayyed, Azizah
    Alrajhi, Abdullah M. M.
    Zaidi, Syed Z. A.
    Motabi, Ibraheem
    AlShehry, Nawal
    Alfayez, Mansour
    HEMATOLOGY, 2022, 27 (01) : 1259 - 1262
  • [5] Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy
    Liu, Yujie
    Tu, Yuqing
    Xiao, Jinyan
    Shen, Yifan
    Zhou, Biqi
    Yang, Qiannan
    Yu, Lei
    Qi, Lijuan
    Chen, Jia
    Liu, Tianhui
    Wu, Depei
    Xu, Yang
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [6] Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy
    Yujie Liu
    Yuqing Tu
    Jinyan Xiao
    Yifan Shen
    Biqi Zhou
    Qiannan Yang
    Lei Yu
    Lijuan Qi
    Jia Chen
    Tianhui Liu
    Depei Wu
    Yang Xu
    Blood Cancer Journal, 14
  • [7] Identification of PML as novel PAX5 fusion partner gene in childhood acute lymphoblastic leukemia
    Nebral, K.
    Siebert, R.
    König, M.
    Haas, O. A.
    Strehl, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 1 - 1
  • [8] 5Q- IN A CASE OF BLASTIC PHASE CHRONIC MYELOID-LEUKEMIA
    DONTI, E
    MECUCCI, C
    VENTI, G
    ROSETTI, A
    CANCER GENETICS AND CYTOGENETICS, 1985, 16 (04) : 365 - 367
  • [9] The Clinical Outcome of Patients with Refractory/Relapsed Lymphoid Blastic Phase of Chronic Myeloid Leukemia Treated with CAR T-Cells Therapy
    Liu, Yujie
    Tu, Yuqing
    Xiao, Jinyan
    Shen, Yifan
    Zhou, Biqi
    Yang, Qiannan
    Liu, Tianhui
    Qi, Lijuan
    Chen, Jia
    Yu, Lei
    Wu, Depei
    Yang, Xu
    BLOOD, 2023, 142
  • [10] A T(3-5) IN BLASTIC PHASE OF A PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOID-LEUKEMIA
    DEBRAEKELEER, M
    VEKEMANS, M
    CANCER GENETICS AND CYTOGENETICS, 1989, 37 (02) : 163 - 168
12345